Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.33M Hold
11,958
2.56% 16
2026
Q1
$4.21M Buy
11,958
+15
+0.1% +$5.35K 2.76% 13
2025
Q4
$3.91M Sell
11,943
-216
-2% -$68.5K 2.64% 14
2025
Q3
$3.43M Buy
12,159
+414
+4% +$120K 2.13% 19
2025
Q2
$3.28M Sell
11,745
-121
-1% -$34.3K 2.31% 17
2025
Q1
$3.7M Sell
11,866
-293
-2% -$86.5K 2.94% 13
2024
Q4
$3.17M Buy
12,159
+1,230
+11% +$365K 2.31% 20
2024
Q3
$3.52M Sell
10,929
-276
-2% -$90.3K 2.77% 16
2024
Q2
$3.5M Sell
11,205
-40
-0.4% -$11.8K 2.66% 17
2024
Q1
$3.2M Sell
11,245
-30
-0.3% -$8.78K 2.44% 18
2023
Q4
$3.25M Buy
11,275
+80
+0.7% +$21.8K 2.82% 15
2023
Q3
$3.01M Buy
11,195
+870
+8% +$217K 2.8% 15
2023
Q2
$2.29M Hold
10,325
2.18% 20
2023
Q1
$2.5M Sell
10,325
-786
-7% -$193K 2.71% 15
2022
Q4
$2.92M Buy
+11,111
New +$2.98M 3.09% 15

Other funds holding AMGN

Ellerson Group's AMGN Position: Q2 2026 in Review

Ellerson Group held its Amgen (AMGN) position steady in Q2 2026 at 11,958 shares worth $4.33M. The position accounts for 2.56% of the portfolio, ranked #16.

Ellerson Group first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ellerson Group held 11,958 shares of Amgen worth $4.33M as of Q2 2026.
  • Ellerson Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 2.56% of Ellerson Group's portfolio in Q2 2026, its #16 holding.
  • Ellerson Group first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ellerson Group's 13F filing for Q2 2026, filed 31 Jul 2026.